Association of anti-GM2 antibodies in Guillain-Barre syndrome with acute cytomegalovirus infection

Journal of Neuroimmunology

Volumn 68, Issue 1-2, 1996, Pages 19-26

  Irie, Sachiko ^a   Saito, Toyokazu ^a   Nakamura, Kazuo ^b   Kanazawa, Naomi ^b   Ogino, Mieko ^a   Nukazawa, Tatsushi ^a   Ito, Hiroaki ^a   Tamai, Yoichi ^b   Kowa, Hisayuki ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti GM2 antibody; Cytomegalovirus; Guillain Barre syndrome

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; IMMUNOGLOBULIN M; VIRUS ANTIBODY; GANGLIOSIDE GM2; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ANTIBODY SPECIFICITY; BLOOD; CARBOHYDRATE ANALYSIS; CASE REPORT; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; POLYRADICULONEUROPATHY; THIN LAYER CHROMATOGRAPHY; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, THIN LAYER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M2) GANGLIOSIDE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYRADICULONEUROPATHY;

EID: 0030201468     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(96)00059-8     Document Type: Article

References (35)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 41:1991;617-618.
2. Adelmann M., Linington C. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Neurochem. Res. 17:1992;887-891.
3. Anumula K.R., Taylor P.B. A comprehensive procedure for preparation of partially methylated alditol acetates from glycoprotein carbohydrates. Anal. Biochem. 203:1992;101-108.
4. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(Suppl.):1990;S21-S24.
5. Bale, Jr., J.F. and Jordan, M.C. (1989) Cytomegalovirus. In: R.R. McKendall (Eds.), Handbook of Clinical Neurology, Vol. 12, Elsevier Science Publishers, Amsterdam, pp. 263-279.
6. Bartholomaeus W.N., O'Donoghue H., Foti D., Lawson C.M., Shellam G.R., Reed W.D. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology. 64:1988;397-405.
7. Boucquey D., Sindic C.J.M., Lamy M., Delmée M., Tomasi J.P., Laterre E.C. Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J. Neurol. Sci. 104:1991;56-63.
8. 1b IgG antibody is associated with opthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
9. 1 and Gal(β1-3)GalNAc antigenic determinants in peripheral nerve. Neurology. 43:1993;809-814.
10. Dalakas M.C., Pezeshkpour G.H. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann. Neurol. 23(Suppl.):1988;S38-S48.
11. Donaghy M., Gray J.A., Squier W., Kurtz J.B., Higgins R.M., Richardson A.J., Morris P.J. Recurrent Guillain-Barré syndrome after multiple exposures to cytomegalovirus. Am. J. Med. 87:1989;339-341.
12. Dowling P.C., Cook S.D. Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpes viruses in 41 cases. Ann. Neurol. 9(Suppl.):1981;44-55.
13. 1b are antigens for IgM M-protein in a patient with motor neuron disease. Neurology. 36:1986;454-458.
14. Gibson, W. (1994) Cytomegaloviruses Molecular biology (human). In: R.G. Webster and A. Granoff (Eds.), Encyclopedia of Virology, Vol. 2, Academic Press, London, pp. 299-304.
15. Grafe M.R., Wiley C.A. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann. Neurol. 25:1989;561-566.
16. Gregson N.A., Koblar S., Hughes R.A.C. Antibodies to gangliosides in Guillain-Barré syndrome; specificity and relationship to clinical features. Q.J. Med. 86:1993;111-117.
17. Griffiths P.D., Grundy J.E. Molecular biology and immunology of cytomegalovirus. Biochem. J. 241:1987;313-324.
18. Hartung H.-P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and treatment of the Guillain-Barré syndrome-Part II. Muscle Nerve. 18:1995;154-164.
19. 1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy. J. Biol. Chem. 263:1988;4369-4373.
20. Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.-W., Cook S.D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107:1992;111-121.
21. Kitamura K., Suzuki M., Uyemura K. Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane. Biochim. Biophys. Acta. 455:1976;806-816.
22. 1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35:1994;570-576.
23. McFarlin D.E. Immunological parameters in Guillain-Barré syndrome. Ann. Neurol. 27(Suppl.):1990;S25-S29.
24. Milner P., Lovelidge C.A., Taylor W.A., Hughes R.A.C. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J. Neurol. Sci. 79:1987;275-285.
25. 1 antibodies. J. Neurol. Sci. 109:1992;200-206.
26. Ogawa-Goto K., Kubota K., Kurotani A., Abe T. Antibodies against sulfated glycosphingolipids of peripheral nerve myelins detected in patients with human cytomegalovirus infection. J. Neuroimmunol. 55:1994;55-60.
27. Quarles R.H., Pasnak C.F. A rapid procedure for selectively isolating the major glycoprotein from purified rat brain myelin. Biochem. J. 163:1977;635-637.
28. 1 antibodies. Neurology. 40:1990;1067-1072.
29. Saito T., Sherman W.H., Latov N. Specificity and idiotype of M-proteins that react with MAG in patients with neuropathy. J. Immunol. 130:1983;2496-2498.
30. Walsh F.S., Cronin M., Koblar S., Doherty P., Winer J., Leon A., Hughes R.A.C. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34:1991;43-51.
31. Winer J.B., Hughes R.A.C., Anderson M.J., Jones D.M., Kangro H., Watkins P.F. A prospective study of acute idiopathic neuropathy. II. Antecedent events J. Neurol. Neurosurg. Psychiat. 51:1988;613-618.
32. 1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann. Neurol. 35:1994;698-703.
33. 1 antibodies following Campylobacter enteritis. Neurology. 40:1990;1990-1902.
34. 1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.
35. 1a antibody with severe Guillain-Barré syndrome. Muscle Nerve. 16:1993;642-647.